2025, Volume 71, Issue 5  |
| REVIEWS |
| 319-332 |
Sarf E.A., Bel`skaya L.V.
Factors of variability in the composition of mixed saliva (a review)
|
  |
| EXPERIMENTAL STUDIES |
| 333-341 |
Mosievich D.V., Balabushevich N.G., Mishin P.I., Le-Deygen I.M., Filatova L.Y., Panasenko O.M., Murina M.A., Vakhrusheva T.V., Barinov N.A., Pobeguts O.V., Galyamina M.A., Gorudko I.V., Grigorieva D.V., Pashkevich K.F., Sokolov A.V., Mikhalchik E.V.
Functional activity features of lactoferrin-fucoidan complexes in model systems in vitro
|
 |
| 342-350 |
Veselova O.M., Serebryakova L.I., Studneva I.M., Azmuko A.A., Avdeev A.V., Sidorova M.V., Pisarenko O.I.
The preconditioning effect of a structural analogue of apelin-12 in a rat model of acute myocardial infarction
|
|
| 351-363 |
Miroshnichenko Yu.V., Rybina A.V., Skvortsov V.S.
Identification of proteins with variable levels of post-translational modifications in human temporal lobe epilepsy
|
|
| CLINICAL AND DIAGNOSTIC RESEARCH |
| 364-374 |
Kukharchuk V.V., Ponomarenko E.A., Lisitsa A.V., Romashova Yu.A., Pleshakova T.O., Yarovaya E.B., Kutsenko V.A., Guseva M.K., Ipatova O.M., Karpova E.A., Zubareva M.Yu., Pyatigorsky A.M., Ivanov S.V., Beregovykh V.V., Kudlai D.A., Markin S.S., Archakov A.I.
Vitaphospholip® (water-soluble phosphatidylcholine) in the treatment of combined hyperlipidemia: a randomized, placebo-controlled clinical trial
|
|